Australia Provisionally OKs Novavax's COVID-19 Vaccine Australia's Therapeutic Goods Administration (TGA) has granted approval for provisional registration of NVX-CoV2373, Novavax's COVID-19 vaccine (adjuvanted). The vaccine will be supplied to Australia under the brand name Nuvaxovid.